I think we are jumping the gun on this potential NBC article. My read of it is a bit different then most reactive posts. They are referring to a “study” and not a specific medication. They refer to “promising results on therapeutics!” Seems like this study could cover a broad range of meds and trials. As for market moving, the study could refer to multiple drugs and their associated manufacturers will definitely get a bump up. Anyway, that is my take on it. Will Leronlimab be discussed? Very possibly!

See the NBC quoted paragraph below:

Next week administration officials plan to promote a new study they say shows promising results on therapeutics, the officials said. They wouldn't describe the study in any further detail because, they said, its disclosure would be "market-moving."